
Scancell Receives FDA Clearance for Global Phase 3 Trial of iSCIB1, Marking a Major Breakthrough in Advanced Melanoma Immunotherapy
Scancell Achieves FDA Clearance for IND Application of iSCIB1 in Advanced Melanoma, a UK-based biotechnology company specializing in innovative cancer...
















































